Related Experiment Video

Updated: Jul 8, 2026

Screening Ion Channels in Cancer Cells
06:19

Screening Ion Channels in Cancer Cells

Published on: June 16, 2023

Voltage-gated ion channels, new targets in anti-cancer research

Jean-Yves Le Guennec1, Halima Ouadid-Ahidouch, Olivier Soriani

  • 1Inserm, E 211, Nutrition Croissance Cancer, Tours, France; Université François-Rabelais de Tours, Tours, France. Jean-Yves.LeGuennec@Univ-Tours.Fr

Recent Patents on Anti-Cancer Drug Discovery
|January 29, 2008
PubMed

Insights

Ion channels, transmembrane proteins, are increasingly recognized for their role in cancer development, influencing tumor cell proliferation, migration, and invasion. Understanding these targets offers new therapeutic strategies for cancer treatment.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biophysics

Background:

  • Cancer remains a leading global cause of mortality, necessitating novel therapeutic strategies beyond conventional treatments.
  • Emerging research highlights the involvement of specific transmembrane proteins, known as ion channels, in cancer development.
  • Ion channels are well-characterized in non-cancerous and excitable cells, suggesting a potential for targeted pharmacological intervention in oncology.

Purpose of the Study:

  • To review the current understanding of ion channel roles in tumor development.
  • To explore the impact of ion channels on key cancer cell properties: proliferation, migration, and invasion.
  • To identify promising new patents related to ion channels as cancer targets.

Main Methods:

  • Literature review of scientific articles and patent databases.
  • Synthesis of existing knowledge on ion channel function in cancer.
  • Analysis of the implications for cancer therapy.

Main Results:

  • Ion channels significantly influence cancer cell proliferation, migration, and invasion.
  • Specific ion channels are implicated in various stages of tumor development.
  • Numerous patents indicate active research and development in targeting ion channels for cancer treatment.

Conclusions:

  • Ion channels represent a promising class of novel targets for cancer therapy.
  • Further research into ion channel pharmacology could lead to improved clinical outcomes.
  • Targeting ion channels offers a potential avenue for developing innovative anti-cancer strategies.

More Related Videos

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

Single-Molecule Localization Microscopy of Membrane Proteins using Single-Antibody Labeling07:51

Single-Molecule Localization Microscopy of Membrane Proteins using Single-Antibody Labeling

Published on: March 20, 2026

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels01:26

Voltage-gated Ion Channels

Voltage-gated ion channels are transmembrane proteins that open and close in response to changes in the membrane potential. They are present on the membranes of all electrically excitable cells such as neurons, heart, and muscle cells.
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Non-gated Ion Channels01:24

Non-gated Ion Channels

Ion channels are specialized proteins on the plasma membrane that allow charged ions to pass down their electrochemical gradient. Their main function is to maintain the membrane potential which is critical for cell viability. These channels are either gated or non-gated and can transport more than a thousand ions within milliseconds for the cellular event to occur.
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Targets for Drug Action: Overview01:26

Targets for Drug Action: Overview

Drugs target macromolecules to modify ongoing cellular processes. Primary drug targets include receptors, ion channels, transporters, and enzymes.
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...